Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Latest filing published 19 Sept 2026 for Coca-Cola HBC AG, €267k. Read the official filing
Filing timeline
BuySaleJan Gustavsson
Insider track record
Disclosed buys
0
Disclosed sells
10
Signal history
Closed purchases
Market purchases
51
Positive at T+90
40%
Median T+90
-0.0%
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -5.8%Entry £45.44 · Close 09 Oct 2026 £42.82
- -3.6%Entry £44.42 · Close 09 Oct 2026 £42.82
- -4.7%Entry £48.16 · Close at T+30 £45.92
- -13.8%Entry £49.70 · Close 09 Oct 2026 £42.82
- -6.8%Entry £45.94 · Close 09 Oct 2026 £42.82
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jan Gustavsson: trading record in brief
This profile gathers the share dealings of Jan Gustavsson in Coca-Cola HBC AG. Over a trading history stretching from 16 June 2023 to 17 September 2026, the count stands at 64 filings.
No open-market purchase appears, only 10 sales worth €9.3M. Besides market trades, the filings include 54 share grants. 2026 to date brings no purchases and 5 sales.
Ninety days after publication, 5 purchases show a median change of -0.0%, with the price up in 40% of them. These figures describe past trades and do not predict future prices.
On 19 September 2026 came the latest disclosure, a share grant for €267k in Coca-Cola HBC AG. The median gap between a trade and its publication by RNS (LSE) is 1 day. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jan Gustavsson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations64 total
4,221.64 shares@ £54.33210.0014% mcap15.5% of flowXLONISIN CH0198251305RNS:9780295-1
Canonical exit: 16 Dec 2026 (T+90)
65.53 shares@ £46.57120.0000% mcap0.2% of flowXLONISIN CH0198251305FCA-NSM:960d7afd-62bb-4960-97fb-623cbb854d43-1
Canonical exit: 16 Dec 2026 (T+90)
3,992.32 shares@ £51.21170.0013% mcap13.9% of flowXLONISIN CH0198251305RNS:9728222-1
Canonical exit: 15 Nov 2026 (T+90)
61.817 shares@ £45.52920.0000% mcap0.2% of flowXLONISIN CH0198251305FCA-NSM:a56dbc51-4cd1-4d4d-9192-e2095a1dd404-1
Canonical exit: 15 Nov 2026 (T+90)
4,008.48 shares@ £47.11060.0012% mcap12.9% of flowXLONISIN CH0198251305RNS:9678059-1
Canonical exit: 15 Oct 2026 (T+90)
56.866 shares@ £49.6450.0000% mcap0.2% of flowXLONISIN CH0198251305FCA-NSM:42e3aacf-a69b-40c3-ad73-57773f9de9e7-1
Canonical exit: 15 Oct 2026 (T+90)
14,000 shares@ £48.00040.0040% mcap6.0% of flowXLONISIN CH0198251305RNS:3c4c6b0b-f9b0-4045-a0d4-a6c79e576abd
14,000 shares@ £48.00040.0044% mcap6.4% of flowXLONISIN CH0198251305RNS:9639071
4,270.82 shares@ £55.08540.0016% mcap15.8% of flowXLONISIN CH0198251305RNS:9626124-1
Canonical exit: 15 Sept 2026 (T+90)
0XLONRNS:c429fc9a-8344-4620-bfca-ad06273394fc-1
Canonical exit: 15 Sept 2026 (T+90)
10,144.598 shares@ £44.76060.0031% mcap30.5% of flowXLONISIN CH0198251305RNS:9619208-1
Canonical exit: 9 Sept 2026 (T+90)
0XLONRNS:9f0bc752-7a6b-44e3-99d8-0fff20d2763f-1
Canonical exit: 9 Sept 2026 (T+90)
4,041.6 shares@ £42.545111.5% of flowXLONISIN CH0198251305RNS:9576123-1
Canonical exit: 16 Aug 2026 (T+90)
0XLONRNS:cfd77d8b-474a-4838-9d16-8d9b51a277e7-1
Canonical exit: 16 Aug 2026 (T+90)
0XLONRNS:e4673e71-fc27-4c38-a628-cfae4bc8b9f0-1
Canonical exit: 16 Jul 2026 (T+90)
31,398 shares@ £42.8160.0094% mcap12.7% of flowXLONISIN CH0198251305RNS:28e99025-53fc-41b3-a1c5-717a297ea0ba-1
20,821 shares@ £44.620.0065% mcap8.8% of flowOUTSIDE A TRADING VENUEISIN CH0198251305RNS:40364c27-a273-467d-9ce9-318f08b0bde1-1
0XLONRNS:b03dfd59-a0d2-4314-b28e-17fab2efb035-1
Canonical exit: 15 Jun 2026 (T+90)
7,313 shares@ £48.103.3% of flowXLONISIN CH0198251305RNS:d6642c8a-38f3-463e-88d0-7f6be486ece0
25,000 shares@ £47.4011.1% of flowXLONISIN CH0198251305RNS:ef8d8570-8fd9-41b3-ac81-2730eac0d9ee
0XLONRNS:c6180186-6052-45b4-a644-171ed0251413-1
Canonical exit: 18 May 2026 (T+90)
0XLONRNS:0b7e599b-e57b-4444-848c-34eae4c62517-1
Canonical exit: 16 Apr 2026 (T+90)
0XLONRNS:cf30e649-c5b6-41d8-9999-457b30522a78-1
Canonical exit: 17 Mar 2026 (T+90)
0XLONISIN CH0198251305RNS:5868283-1
Canonical exit: 15 Jan 2026 (T+90)
0XLONISIN CH0198251305RNS:5826797-1
Canonical exit: 16 Dec 2025 (T+90)
25 of 64 declarations
